Articles

Sort by
Previous Page Page 2 of 9 Next Page
  1. Short Report

    Impact of switching from intravenous to oral linezolid therapy in Japanese patients: a retrospective cohort study

    High oral bioavailability of antimicrobial agents can result in the replacement of intravenous (IV) therapy with oral therapy when a patient meets defined clinical criteria. However, few studies have evaluated...

    Akihiro Tanaka, Akiko Yano, Shinichi Watanabe, Mamoru Tanaka and Hiroaki Araki

    Journal of Pharmaceutical Policy and Practice 2016 9:35

    Published on: 28 October 2016

  2. Research

    An assessment of the future impact of alternative technologies on antibiotics markets

    The increasing threat of antimicrobial resistance combined with the paucity of new classes of antibiotics represents a serious public health challenge. New treatment technologies could, in theory, have a signi...

    Ejike Nwokoro, Ross Leach, Christine Årdal, Enrico Baraldi, Kellie Ryan and Jens Plahte

    Journal of Pharmaceutical Policy and Practice 2016 9:34

    Published on: 26 October 2016

  3. Editorial

    Medicine and the future of health: reflecting on the past to forge ahead

    The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between me...

    Dale Fisher, Paul Wicks and Zaheer-Ud-Din Babar

    Journal of Pharmaceutical Policy and Practice 2016 9:33

    Published on: 25 October 2016

  4. Research

    Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015

    Annual immunization is the most effective way to prevent influenza and its associated complications. However, optimal immunization rates are not being met in Nova Scotia, Canada. Additional providers, such as ...

    Jennifer E. Isenor, Jessica L. Killen, Beverly A. Billard, Shelly A. McNeil, Donna MacDougall, Beth A. Halperin, Kathryn L. Slayter and Susan K. Bowles

    Journal of Pharmaceutical Policy and Practice 2016 9:32

    Published on: 19 October 2016

  5. Review

    Towards the just and sustainable use of antibiotics

    The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-makers, who need to oversee the transformation of health systems that evolved to provide easy access to these drugs in...

    Gemma L. Buckland Merrett, Gerald Bloom, Annie Wilkinson and Hayley MacGregor

    Journal of Pharmaceutical Policy and Practice 2016 9:31

    Published on: 7 October 2016

  6. Research

    Fighting falsified medicines with paperwork – a historic review of Danish legislation governing distribution of medicines

    Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation ...

    Rasmus Borup, Susanne Kaae, Timo Minssen and Janine Traulsen

    Journal of Pharmaceutical Policy and Practice 2016 9:30

    Published on: 6 October 2016

  7. Research

    Novel models to improve access to medicines for chronic diseases in South Africa: an analysis of stakeholder perspectives on community-based distribution models

    The rising demand for chronic disease treatment and the barriers to accessing these medicines have led to the development of novel models for distributing medicines in South Africa’s public sector, including d...

    Bvudzai Priscilla Magadzire, Bruno Marchal and Kim Ward

    Journal of Pharmaceutical Policy and Practice 2016 9:28

    Published on: 1 October 2016

  8. Review

    Is there potential for the future provision of triage services in community pharmacy?

    Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments...

    Louise E. Curley, Janice Moody, Rukshar Gobarani, Trudi Aspden, Maree Jensen, Maureen McDonald, John Shaw and Janie Sheridan

    Journal of Pharmaceutical Policy and Practice 2016 9:29

    Published on: 29 September 2016

  9. Research

    Use of a fictitious community-based virtual teaching platform to aid in the teaching of pharmacy practice skills: Student perspectives after initial implementation

    Providing patient-centred care requires pharmacy students to learn how to interact effectively and understand individual differences that can influence patients’ health. The School of Pharmacy at The University o...

    Louise E. Curley, Maureen McDonald and Trudi Aspden

    Journal of Pharmaceutical Policy and Practice 2016 9:24

    Published on: 22 September 2016

  10. Research

    Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan

    Medicines are a main therapeutic intervention provided within hospitals and their proper use in the outpatient setting is important for patients and the community. The objective of this study was to evaluate d...

    Muhammad Atif, Muhammad Rehan Sarwar, Muhammad Azeem, Danial Umer, Abdul Rauf, Arslan Rasool, Muhammad Ahsan and Shane Scahill

    Journal of Pharmaceutical Policy and Practice 2016 9:27

    Published on: 22 September 2016

  11. Commentary

    The fate of the new pharmacy bill: going backwards or forwards?

    The proposed Pharmacy Bill of Malaysia which served to consolidate and harmonise the existing pharmacy legislation which has been used for more than 60 years. This new Pharmacy Bill contains 17 parts and a tot...

    Kah Seng Lee, Yen Wei Lim and Long Chiau Ming

    Journal of Pharmaceutical Policy and Practice 2016 9:25

    Published on: 22 September 2016

  12. Research

    Prescription medicine sharing: exploring patients’ beliefs and experiences

    Prescription medicine sharing has been defined as the lending of medicines (giving prescription medicines to someone else) or borrowing of medicines (being given and using a medicine prescribed for another per...

    Kebede Beyene, Trudi Aspden and Janie Sheridan

    Journal of Pharmaceutical Policy and Practice 2016 9:23

    Published on: 9 September 2016

  13. Research

    Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan

    Pharmacists in Japan currently play a key role in patient hospital care. Their responsibilities include filling prescriptions, checking a patient’s medication history, and providing appropriate information to ...

    Daiki Yasunaga, Yuichi Tasaka, Satoshi Murakami, Akihiro Tanaka, Mamoru Tanaka and Hiroaki Araki

    Journal of Pharmaceutical Policy and Practice 2016 10:2

    Published on: 19 July 2016

  14. Research

    Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India

    Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formul...

    Anandhasayanam Aravamuthan, Mohanavalli Arputhavanan, Kannan Subramaniam and Sam Johnson Udaya Chander J

    Journal of Pharmaceutical Policy and Practice 2016 10:1

    Published on: 19 July 2016

  15. Research

    ‘Better medicines for children’ within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda

    The Integrated Management of Childhood Illnesses is the main approach for treating children in more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate ‘bet...

    Xavier Nsabagasani, Japer Ogwal-Okeng, Ebba Holme Hansen, Anthony Mbonye, Herbert Muyinda and Freddie Ssengooba

    Journal of Pharmaceutical Policy and Practice 2016 9:22

    Published on: 7 June 2016

  16. Research

    Article 1: Supervision, Performance Assessment, and Recognition Strategy (SPARS) - a multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline

    Uganda introduced a multipronged intervention, the supervision, performance assessment, and recognition strategy (SPARS), to improve medicines management (MM) in public and not-for-profit health facilities. Th...

    Birna Trap, Denis Okidi Ladwar, Martin Olowo Oteba, Martha Embrey, Mohammed Khalid and Anita Katharina Wagner

    Journal of Pharmaceutical Policy and Practice 2016 9:21

    Published on: 31 May 2016

  17. Research

    Experiences from a pilot study on how to conduct a qualitative multi-country research project regarding use of antibiotics in Southeast Europe

    In 2014, a qualitative multi-country research project was launched to study the reasons behind the high use of antibiotics in regions of Southeast Europe by using previously untrained national interviewers (wh...

    Susanne Kaae, Sofia Kälvemark Sporrong, Janine Morgall Traulsen, Helle Wallach Kildemoes, Lotte Stig Nørgaard, Arianit Jakupi, Denis Raka, Emre Umut Gürpinar, Ali Alkan, Iris Hoxha, Admir Malaj and Lourdes Arevalo Cantarero

    Journal of Pharmaceutical Policy and Practice 2016 9:20

    Published on: 23 May 2016

  18. Editorial

    Using health markets to improve access to medicines: three case studies

    This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the a...

    Zubin Shroff, Maryam Bigdeli, Zaheer-Ud-Din Babar, Anita Wagner, Abdul Ghaffar and David H Peters

    Journal of Pharmaceutical Policy and Practice 2016 9:19

    Published on: 6 May 2016

  19. Research

    First regulatory inspections measuring adherence to Good Pharmacy Practices in the public sector in Uganda: a cross-sectional comparison of performance between supervised and unsupervised facilities

    Since its inception, the Uganda National Drug Authority (NDA) has regularly inspected private sector pharmacies to monitor adherence to Good Pharmacy Practices (GPP). This study reports findings from the first...

    Birna Trap, Kate Kikule, Catherine Vialle-Valentin, Richard Musoke, Grace Otto Lajul, Kim Hoppenworth and Dorthe Konradsen

    Journal of Pharmaceutical Policy and Practice 2016 9:18

    Published on: 4 May 2016

  20. Research

    Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis

    India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutica...

    Charles Newman, Vamadevan S. Ajay, Ravi Srinivas, Sandeep Bhalla, Dorairaj Prabhakaran and Amitava Banerjee

    Journal of Pharmaceutical Policy and Practice 2016 9:16

    Published on: 2 May 2016

  21. Letter to the Editor

    Upstream solutions for price-gouging on critical generic medicines

    Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has foc...

    Adam R. Houston, Reed F. Beall and Amir Attaran

    Journal of Pharmaceutical Policy and Practice 2016 9:15

    Published on: 2 May 2016

  22. Research

    A cross-sectional survey of pharmacists to understand their personal preference of brand and generic over-the-counter medications used to treat common health conditions

    Consumers are hesitant in choosing generic medications as they are under the assumption that they are not as safe nor effective as brand medications. However, pharmacists do have the education and training to ...

    Mira Patel, Marion Slack, Janet Cooley and Sandipan Bhattacharjee

    Journal of Pharmaceutical Policy and Practice 2016 9:17

    Published on: 21 April 2016

Previous Page Page 2 of 9 Next Page